Medicare Enrolled
Dr. Tanya Rodgers, MD
Optician · Allen, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rodgers from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodgers?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rodgers
Dr. Tanya Rodgers is an optician specialist in Allen, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rodgers performed 3,269 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rodgers received a total of $11,541 from 48 pharmaceutical and/or device companies across 576 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodgers is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 21% volume in TX
$11,541 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,269
Medicare services
Top 21% in TX for optician
Not available
Unique patients (not deduplicated)
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
984 | $5 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
798 | $63 | $176 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
347 | $36 | $131 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
241 | $67 | $197 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
209 | $81 | $221 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
124 | $39 | $98 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
116 | $1 | $5 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $40 | $111 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $94 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
63 | $71 | $218 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
43 | $51 | $139 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
34 | $227 | $593 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
32 | $132 | $330 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
30 | $96 | $477 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
25 | $39 | $114 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
22 | $42 | $142 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
17 | $92 | $246 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
16 | $78 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
17.3% medium
82.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,541
Total received (2018-2024)
Avg $1,649/year across 7 years
Top 15% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
576
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,014
2023
$1,266
2022
$519
2021
$1,218
2020
$1,578
2019
$1,314
2018
$2,632
Payments by company (2024)
Galderma Laboratories, L.P.
$1,790
ABBVIE INC.
$295
PFIZER INC.
$176
LEO Pharma Inc.
$122
MAYNE PHARMA COMMERCIAL LLC
$100
Lilly USA, LLC
$62
Novartis Pharmaceuticals Corporation
$56
SUN PHARMACEUTICAL INDUSTRIES INC.
$50
Biofrontera Inc.
$44
GENZYME CORPORATION
$41
Almirall LLC
$38
Helsinn Therapeutics (U.S.), Inc.
$35
Solta Medical, a division of Bausch Health US, LLC
$27
Amgen Inc.
$26
MERZ NORTH AMERICA, INC.
$24
Tempus AI, Inc
$21
Verrica Pharmaceuticals Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$19
E.R. Squibb & Sons, L.L.C.
$18
Dermavant Sciences, Inc.
$15
Arcutis Biotherapeutics, Inc.
$14
Top 3 companies account for 75.0% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$2,217
VYNE Pharmaceuticals Inc.
$1,372
PFIZER INC.
$1,049
Encore Dermatology Inc.
$788
Medimetriks Pharmaceuticals, Inc.
$659
Lilly USA, LLC
$534
GENZYME CORPORATION
$451
LEO Pharma Inc.
$393
Regeneron Healthcare Solutions, Inc.
$346
ABBVIE INC.
$315
Ortho Dermatologics, a division of Bausch Health US, LLC
$275
AbbVie Inc.
$263
Novartis Pharmaceuticals Corporation
$214
MERZ NORTH AMERICA, INC.
$211
UCB, Inc.
$180
MAYNE PHARMA INC.
$162
E.R. Squibb & Sons, L.L.C.
$161
MAYNE PHARMA COMMERCIAL LLC
$158
AbbVie, Inc.
$153
Mayne Pharma Inc.
$149
Almirall LLC
$141
Sun Pharmaceutical Industries Inc.
$125
Incyte Corporation
$103
Biofrontera Inc.
$103
DERMIRA, INC.
$87
SUN PHARMACEUTICAL INDUSTRIES INC.
$85
Bayer HealthCare Pharmaceuticals Inc.
$83
Amgen Inc.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
EPI Health, LLC
$71
Promius Pharma LLC
$71
Helsinn Therapeutics (U.S.), Inc.
$66
Taro Pharmaceuticals USA, Inc.
$56
Janssen Biotech, Inc.
$48
Aclaris Therapeutics, Inc.
$47
Exeltis, USA Inc.
$35
Allergan, Inc.
$31
PruGen, Inc. Pharmaceuticals
$28
Solta Medical, a division of Bausch Health US, LLC
$27
Tempus AI, Inc
$21
Verrica Pharmaceuticals Inc.
$20
Mission Pharmacal Company
$16
Dermavant Sciences, Inc.
$15
Arcutis Biotherapeutics, Inc.
$14
Kyowa Kirin, Inc.
$13
Allergan Inc.
$12
Mylan Pharmaceuticals Inc.
$12
Tactile Systems Technology Inc
$12
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
0.25% · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Ameluz · Avar · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindacin Pac · Clindamycin Phosphate and Benzoyl Peroxide · Clodan Kit · Clodan Shampoo · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Ecoza · FINACEA · FLEXITOUCH · Finacea · Genadur · HUMIRA · Humira · ILUMYA · Ilumya · Impoyz · JUBLIA · Klisyri · LIBTAYO · LITFULO · Merlin Test · Neo-Synalar · Neo-Synalar Cream · Neo-Synalar Cream Kit · Neuac Kit · Nicadan · OLUMIANT · OPZELURA · ORACEA · Otezla · Poteligeo · Promiseb Complete · QBREXZA · RETIN-A-MICRO · RHOFADE · RINVOQ · Recedo · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo Spray · Seysara · Sitavig · Sotyktu · Sumadan Kit · Sumadan XLT · TALTZ · TETRIX · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Trianex · ULTRAVATE (halobetasol propionate) lotion · VALCHLOR · VTAMA · Veltin · Winlevi · Xeomin · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
439
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL ALLEN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rodgers is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rodgers experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Rodgers performed 984 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rodgers receive payments from pharmaceutical companies?
Yes. Dr. Rodgers received a total of $11,541 from 48 companies across 576 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodgers's costs compare to other opticians in Allen?
Dr. Rodgers's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodgers) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Allen
Browse opticians in Allen ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
VYNE Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from VYNE Pharmaceuticals Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology